Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway

The mortality rate of non-small-cell lung cancer (NSCLC) remains high worldwide. Although cisplatin-based chemotherapy may greatly enhance patient prognosis, chemotherapy resistance remains an obstacle to curing patients with NSCLC. Therefore, overcoming drug resistance is the main route to successf...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Li-Mei, Liao, Xiao-Zhong, Zhang, Yan, He, Zi-Rui, Nie, Shi-Qing, Ke, Bin, Shi, Lin, Zhao, Jian-Fu, Chen, Wen-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892899/
https://www.ncbi.nlm.nih.gov/pubmed/33614623
http://dx.doi.org/10.3389/fcell.2020.610097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892899/
https://www.ncbi.nlm.nih.gov/pubmed/33614623
http://dx.doi.org/10.3389/fcell.2020.610097

Ejemplares similares